Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J Will "Repatriate" Up To $10 Bil. In Foreign-Held Cash If Bill Is Signed

This article was originally published in The Pink Sheet Daily

Executive Summary

Company expects to spend about $350 mil. to $500 mil. to bring the foreign-held cash to U.S.-based accounts. Cash might be used to fund pipeline. J&J continues to work toward achieving $1 bil. annual cost savings.

You may also be interested in...



Bristol Will Repatriate Foreign Cash, Fourth Quarter Charge Expected

Bristol-Myers Squibb intends to take full advantage of a new law allowing companies to repatriate cash held by foreign subsidiaries at a reduced tax rate

Bristol Will Repatriate Foreign Cash, Fourth Quarter Charge Expected

Bristol-Myers Squibb intends to take full advantage of a new law allowing companies to repatriate cash held by foreign subsidiaries at a reduced tax rate

Pfizer Leaves Itself Open To Possible Sales Force Reductions

The company has backed away from its earlier position that any reductions would be unlikely. The follows another quarter of lackluster performances by the recently launched Caduet and Inspra.

Related Content

Topics

UsernamePublicRestriction

Register

LL111109

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel